Founded in 2012 at the National University of Ireland, Galway, by Lokesh Joshi, Stokes Professor of Glycoscience. We have developed revolutionary decontamination technology in collaboration with the Czech University of Defence and Defence Forces Ireland, that protects against harmful pathogens and other viral infections like coronavirus.
We have successfully applied this technology and launched the first Aquila Bioscience product, “ABD device”. It is free from alcohol and toxic chemicals, and is a biodegradable Class I device that safely captures, removes and neutralizes harmful pathogens and viral infections like coronavirus from the skin including eyes nose and mouth plus sensitive and hard surfaces such as screens, workbenches, desks etc.
Our experienced R&D team bring together a range of science disciplines, bridging Glycobiology, Immunology, Microbiology, biochemistry and analytical chemistry.
Company’s Keywords:
glycomics, cellbased assays, immunology, biological adhesion
9
medical devices
5854000
Mimecast, Outlook, Hubspot, Flywheel, Woo Commerce, Hotjar, Facebook Login (Connect), Mobile Friendly, YouTube, Typekit, Facebook Custom Audiences, Google Tag Manager, Bootstrap Framework, Stripe, Google Font API, Facebook Widget, Cvent, WordPress.org
2012
Your request has been submitted successfully.
Own or work here?